|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
IL93173A0
(en)
|
1989-02-01 |
1990-11-05 |
Shionogi & Co |
Production of glucagon
|
|
US5408037A
(en)
|
1991-01-17 |
1995-04-18 |
Zymogenetics, Inc. |
Methods for detecting glucagon antagonists
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5480867A
(en)
|
1993-12-29 |
1996-01-02 |
The Rockefeller University |
Glucagon analogs with serine replacements
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
CZ120398A3
(cs)
|
1995-09-08 |
1998-12-16 |
Novo Nordisk A/S |
Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty
|
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
|
WO1997041097A2
(en)
|
1996-12-31 |
1997-11-06 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
JP2000514041A
(ja)
|
1996-07-26 |
2000-10-24 |
ドクター・レディーズ・リサーチ・ファウンデーション |
抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物
|
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
|
EP0981526B1
(en)
|
1997-05-02 |
2004-02-25 |
Dr. Reddy's Laboratories Ltd. |
Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
WO1999001423A1
(en)
|
1997-07-01 |
1999-01-14 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
AU757693B2
(en)
|
1997-07-16 |
2003-03-06 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
WO1998045292A1
(en)
|
1997-12-02 |
1998-10-15 |
Dr. Reddy's Research Foundation |
Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
|
|
EP1123297A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023445A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023416A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023425A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU6190199A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
EP1123269A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
KR20010086126A
(ko)
|
1998-12-18 |
2001-09-07 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체 및 그의 제법 및 용도
|
|
WO2000041121A1
(en)
|
1999-01-07 |
2000-07-13 |
Ccrewards.Com |
Method and arrangement for issuance and management of digital coupons and sales offers
|
|
AU3033500A
(en)
|
1999-01-15 |
2000-08-01 |
Agouron Pharmaceuticals, Inc. |
Non-peptide glp-1 agonists
|
|
WO2000042023A1
(en)
|
1999-01-18 |
2000-07-20 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
|
WO2000063189A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
|
AU2953699A
(en)
|
1999-04-16 |
2000-11-02 |
Dr. Reddy's Research Foundation |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
|
EP1173438A1
(en)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
|
IL145958A0
(en)
|
1999-04-16 |
2002-07-25 |
Reddy Research Foundation |
Polymorphic form of arginine salt of (2s)-3-[4-[2-phenoxazin-10-yl)ethoxy] phenyl]2-ethoxypropanoic acid, processes for the preparation thereof and pharmaceutical compositions containing the same
|
|
JP2002542246A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
|
EP1171431A1
(en)
|
1999-04-20 |
2002-01-16 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
HUP0200807A3
(en)
|
1999-04-20 |
2003-03-28 |
Novo Nordisk As |
Substituted propionic acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use
|
|
AU3958200A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000064884A1
(en)
|
1999-04-26 |
2000-11-02 |
Novo Nordisk A/S |
Piperidyl-imidazole derivatives, their preparations and therapeutic uses
|
|
PT1180121E
(pt)
|
1999-05-17 |
2004-03-31 |
Conjuchem Inc |
Peptidos insulinotropicos de longa duracao
|
|
AU765753B2
(en)
|
1999-05-17 |
2003-09-25 |
Conjuchem Biotechnologies Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
DE60137876D1
(de)
|
2000-06-16 |
2009-04-16 |
Lilly Co Eli |
Analoge des Glucagon-ähnlichen Peptids-1
|
|
CA2416229C
(en)
|
2000-07-20 |
2007-09-18 |
F. Hoffmann-La Roche Ag |
Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
|
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
|
EP2292273A3
(en)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US8048408B2
(en)
|
2002-01-16 |
2011-11-01 |
Biocompatibles Uk Limited |
Polymer conjugates
|
|
US6953787B2
(en)
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
|
NZ541365A
(en)
|
2002-12-27 |
2009-09-25 |
Diobex Inc |
Compositions and methods for the prevention and control of insulin-induced hypoglycemia
|
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
|
EP1503283A1
(en)
|
2003-08-01 |
2005-02-02 |
Hewlett-Packard Development Company, L.P. |
Data processing system and method
|
|
AU2004261353B2
(en)
|
2003-08-05 |
2009-12-10 |
Novo Nordisk A/S |
Novel insulin derivatives
|
|
EP1654290B1
(en)
|
2003-08-12 |
2019-03-13 |
Lipoxen Technologies Limited |
Sialic acid derivatives for protein derivatisation and conjugation
|
|
CN100444898C
(zh)
|
2003-09-19 |
2008-12-24 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
RU2401276C2
(ru)
|
2003-09-19 |
2010-10-10 |
Ново Нордиск А/С |
Производные глюкагон-подобного пептида-1 (glp-1)
|
|
EP1670515A2
(en)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
DK2371856T3
(en)
|
2004-11-12 |
2022-08-08 |
Bayer Healthcare Llc |
Site-directed modifikation af FVIII
|
|
US8217154B2
(en)
|
2005-02-23 |
2012-07-10 |
Lipoxen Technologies Limited |
Activated sialic acid derivatives for protein derivatisation and conjugation
|
|
EP1863537A2
(en)
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Dimeric peptide agonists of the glp-1 receptor
|
|
US20080227691A1
(en)
|
2005-04-01 |
2008-09-18 |
Novo Nordisk Health Care Ag |
Blood Coagulation FVIII Analogues
|
|
EP1891105B1
(en)
|
2005-06-13 |
2012-04-11 |
Imperial Innovations Limited |
Oxyntomodulin analogues and their effects on feeding behaviour
|
|
BRPI0611570A2
(pt)
|
2005-06-15 |
2011-02-22 |
Novo Nordisk Healthcare Ag |
métodos para fixar covalentemente peg a um polipeptìdeo e para modificar propriedades farmacológicas de hormÈnio de crescimento, composto e sais, pró-drogas ou solvatos farmaceuticamente aceitáveis do mesmo, hormÈnio de crescimento humano, composição farmacêutica, método para tratamento de doença e, uso de um composto
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
CA2913805A1
(en)
|
2005-11-07 |
2007-05-18 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting physiological solubility and stability
|
|
WO2007087711A1
(en)
|
2006-01-31 |
2007-08-09 |
National Research Council Of Canada |
Production of polysialic acid containing glyconjugates using a self-priming polysialyltransferase
|
|
EP2471810A1
(en)
|
2006-02-22 |
2012-07-04 |
Merck Sharp & Dohme Corporation |
Oxyntomodulin derivatives
|
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
|
WO2007126808A1
(en)
|
2006-03-31 |
2007-11-08 |
Baxter International Inc |
Pegylated factor viii
|
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
|
DK2101821T3
(da)
|
2006-12-15 |
2014-10-06 |
Baxter Healthcare Sa |
Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
|
|
CN101578102B
(zh)
|
2007-01-05 |
2013-07-17 |
印第安纳大学研究及科技有限公司 |
在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
|
|
NZ578948A
(en)
|
2007-02-15 |
2012-03-30 |
Univ Indiana Res & Tech Corp |
Glucagon/glp-1 receptor co-agonists
|
|
EP2162535A4
(en)
|
2007-06-04 |
2011-02-23 |
Novo Nordisk As |
O-linked glycosylation using N-acetylglucosamine transferases
|
|
WO2008152403A1
(en)
|
2007-06-15 |
2008-12-18 |
Zealand Pharma A/S |
Glucagon analogues
|
|
US8460909B2
(en)
|
2007-06-15 |
2013-06-11 |
National Research Council Of Canada |
Engineered versions of polysialyltransferases with enhanced enzymatic properties
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
JP2010538996A
(ja)
*
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
単独またはＴｈｒ−Ｔｈｒ−Ｓｅｒ−Ｇｌｎ−Ｖａｌ−Ａｒｇ−Ｐｒｏ−Ａｒｇ−ＯＨのペプチドとの組合せにおけるＡｓｎ−Ａｓｐ−Ａｓｐ−Ｃｙｓ−Ｇｌｕ−Ｌｅｕ−Ｃｙｓ−Ｖａｌ−Ａｓｎ−Ｖａｌ−Ａｌａ−Ｃｙｓ−Ｔｈｒ−Ｇｌｙ−Ｃｙｓ−Ｌｅｕ−ＯＨのペプチドの治療剤としての使用
|
|
AU2008323768A1
(en)
|
2007-11-09 |
2009-05-14 |
Baxter Healthcare S.A. |
Modified recombinant Factor VIII and von Willebrand Factor and methods of use
|
|
US20100317057A1
(en)
|
2007-12-28 |
2010-12-16 |
Novo Nordisk A/S |
Semi-recombinant preparation of glp-1 analogues
|
|
CN102037004A
(zh)
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
|
US20110065633A1
(en)
|
2008-01-30 |
2011-03-17 |
Indiana University Research And Technology Corporation |
Ester-based peptide prodrugs
|
|
US20130189239A1
(en)
|
2008-02-27 |
2013-07-25 |
Novo Nordisk A/S |
Conjugated Factor VIII Molecules
|
|
ES2558842T3
(es)
|
2008-06-17 |
2016-02-09 |
Indiana University Research And Technology Corporation |
Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad
|
|
TWI541023B
(zh)
|
2008-06-17 |
2016-07-11 |
印第安納大學科技研究公司 |
在生理ｐｈ緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
|
|
CA2728284C
(en)
|
2008-06-17 |
2019-09-10 |
Richard D. Dimarchi |
Glucagon/glp-1 receptor co-agonists
|
|
PT2349342T
(pt)
|
2008-10-17 |
2018-10-26 |
Baxalta Inc |
Factores sanguíneos modificados que compreendem um baixo grau de polímero solúvel na água
|
|
US8642540B2
(en)
|
2008-12-15 |
2014-02-04 |
Zealand Pharma A/S |
Glucagon analogues
|
|
ES2502218T3
(es)
*
|
2008-12-15 |
2014-10-03 |
Zealand Pharma A/S |
Análogos de glucagón
|
|
MA32970B1
(fr)
|
2008-12-15 |
2012-01-02 |
Zealand Pharma As |
Analogues du glucagon
|
|
AU2008365557A1
(en)
|
2008-12-15 |
2011-07-21 |
Zealand Pharma A/S |
Glucagon analogues
|
|
US20110306551A1
(en)
|
2009-02-19 |
2011-12-15 |
Novo Nordisk A/S |
Modification of Factor VIII
|
|
WO2010148089A1
(en)
|
2009-06-16 |
2010-12-23 |
Indiana University Research And Technology Corporation |
Gip receptor-active glucagon compounds
|
|
JP6054742B2
(ja)
|
2009-07-13 |
2016-12-27 |
ジーランド ファーマ アクティーゼルスカブ |
アシル化グルカゴン類似体
|
|
GB0917072D0
(en)
|
2009-09-29 |
2009-11-11 |
Univ Ulster |
Peptide analogues of glucagon for diabetes therapy
|
|
WO2011075393A2
(en)
|
2009-12-18 |
2011-06-23 |
Indiana University Research And Technology Corporation |
Glucagon/glp-1 receptor co-agonists
|
|
WO2011088837A1
(en)
|
2010-01-20 |
2011-07-28 |
Zealand Pharma A/S |
Treatment of cardiac conditions
|
|
WO2011117417A1
(en)
|
2010-03-26 |
2011-09-29 |
Novo Nordisk A/S |
Novel glucagon analogues
|
|
AR081975A1
(es)
|
2010-06-23 |
2012-10-31 |
Zealand Pharma As |
Analogos de glucagon
|
|
CA2802897A1
(en)
|
2010-06-24 |
2011-12-29 |
Zealand Pharma A/S |
Glucagon analogues
|
|
WO2011163473A1
(en)
|
2010-06-25 |
2011-12-29 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
|
|
RU2013133803A
(ru)
*
|
2010-12-22 |
2015-01-27 |
Маркадиа Байотек, Инк. |
Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп
|
|
NZ612297A
(en)
*
|
2010-12-22 |
2015-10-30 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting gip receptor activity
|
|
EA201390796A1
(ru)
|
2011-01-20 |
2014-07-30 |
Зилэнд Фарма А/С |
Применение ацилированного аналога глюкагона
|
|
RU2013145013A
(ru)
|
2011-03-28 |
2015-05-10 |
Ново Нордиск А/С |
Новые аналоги глюкагона
|
|
US9790262B2
(en)
|
2011-04-05 |
2017-10-17 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
|
WO2012150503A2
(en)
|
2011-05-03 |
2012-11-08 |
Zealand Pharma A/S |
Glu-glp-1 dual agonist signaling-selective compounds
|
|
EP4286400A3
(en)
|
2011-05-18 |
2024-06-05 |
Eumederis Pharmaceuticals, Inc. |
Improved peptide pharmaceuticals
|
|
CA3134906A1
(en)
|
2011-05-18 |
2012-11-22 |
Mederis Diabetes, Llc |
Improved peptide pharmaceuticals for insulin resistance
|
|
HRP20181591T1
(hr)
|
2011-06-10 |
2018-11-30 |
Hanmi Science Co., Ltd. |
Novi derivati oksintomodulina i farmaceutski pripravci za liječenje pretilosti koji ih sadrže
|
|
JP6184404B2
(ja)
*
|
2011-06-22 |
2017-08-23 |
インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション |
グルカゴン／ｇｌｐ−１レセプターコアゴニスト
|
|
CN103857408B
(zh)
|
2011-06-22 |
2017-04-12 |
印第安那大学科技研究公司 |
胰高血糖素/glp‑1受体协同激动剂
|
|
BR112015025464A2
(pt)
|
2013-04-18 |
2017-10-10 |
Novo Nordisk As |
coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico
|
|
TW201609797A
(zh)
*
|
2013-12-13 |
2016-03-16 |
賽諾菲公司 |
雙重ｇｌｐ－１／升糖素受體促效劑
|
